Drug Shortage Report for MINT-QUETIAPINE XR
Report ID | 217387 |
Drug Identification Number | 02522195 |
Brand name | MINT-QUETIAPINE XR |
Common or Proper name | Quetiapine |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 count bottle |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-18 |
Estimated end date | 2025-05-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2025-04-11 | French | Compare |
v9 | 2025-04-11 | English | Compare |
v8 | 2025-03-03 | French | Compare |
v7 | 2025-03-03 | English | Compare |
v6 | 2024-12-05 | French | Compare |
v5 | 2024-12-05 | English | Compare |
v4 | 2024-07-08 | French | Compare |
v3 | 2024-07-08 | English | Compare |
v2 | 2024-01-26 | French | Compare |
v1 | 2024-01-26 | English | Compare |
Showing 1 to 10 of 10